Shen Tao, Dong Tingting, Wang Haiyang, Ding Yi, Zhang Jianuo, Zhu Xinyi, Ding Yeping, Cai Wen, Wei Yalan, Wang Qiao, Wang Sufen, Jiang Feiyun, Tang Bin
Anhui Provincial Key Laboratory of Molecular Enzymology and Mechanism of Major Metabolic Diseases, Anhui Provincial Engineering Research Centre for Molecular Detection and Diagnostics, College of Life Sciences, Anhui Normal University, Wuhu, China.
Department of Gynecology, East China Normal University Wuhu Affiliated Hospital (The Second People's Hospital of Wuhu City), Wuhu, 241000, China.
BMC Cancer. 2025 Jan 10;25(1):57. doi: 10.1186/s12885-025-13454-z.
Neuroendocrine cervical carcinoma (NECC) is a rare but highly aggressive tumor. The clinical management of NECC follows neuroendocrine neoplasms and cervical cancer in general. However, the diagnosis and prognosis of NECC remain dismal. The aim of this study was to identify a specific protein signature for the diagnosis of NECC.
Protein and gene expression data for NECC and other cervical cancers were retrieved or downloaded from self-collected samples or public resources. Eleven machine-learning algorithms were packaged into 66 combinations, of which we selected the optimal algorithm, including randomForest, SVM-RFE, and LASSO, to select key NECC specific dysregulated proteins (kNsDEPs). The diagnostic effect of kNsDEPs was validated by a set of predictive models and immunohistochemical staining method. The dysregulation patterns of kNsDEPs were further investigated in other neuroendocrine carcinomas.
Our results showed that NECC displays distinctive biological characteristics, such as HPV18 infection, and exhibits unique molecular features, particularly an enrichment in cytoskeleton-related functions. Furthermore, secretagogin (SCGN), adenylyl cyclase-associated protein 2 (CAP2), and calcyclin-binding protein (CACYBP) were identified as kNsDEPs. These kNsDEPs play a central role in cytoskeleton protein binding and showcase robust diagnostic ability and specificity for NECC. Moreover, the concurrent upregulation of SCGN and CACYBP, along with the downregulation of CAP2, represents a unique feature of NECC, distinguishing it from other neuroendocrine carcinomas.
This study uncovers the significance of kNsDEPs and elucidates their regulated networks in the context of NECC. It highlights the pivotal role of kNsDEPs in NECC diagnosis, thus offering promising prospects for the development of diagnostic biomarkers for NECC.
神经内分泌宫颈癌(NECC)是一种罕见但侵袭性很强的肿瘤。NECC的临床管理总体上遵循神经内分泌肿瘤和宫颈癌的管理方式。然而,NECC的诊断和预后仍然不容乐观。本研究的目的是确定一种用于诊断NECC的特定蛋白质标志物。
从自行采集的样本或公共资源中检索或下载NECC和其他宫颈癌的蛋白质和基因表达数据。将11种机器学习算法打包成66种组合,从中选择最佳算法,包括随机森林、支持向量机递归特征消除法(SVM-RFE)和套索回归法(LASSO),以选择关键的NECC特异性失调蛋白(kNsDEPs)。通过一组预测模型和免疫组织化学染色方法验证kNsDEPs的诊断效果。在其他神经内分泌癌中进一步研究kNsDEPs的失调模式。
我们的结果表明,NECC具有独特的生物学特征,如HPV18感染,并表现出独特的分子特征,特别是在细胞骨架相关功能方面富集。此外,分泌粒蛋白(SCGN)、腺苷酸环化酶相关蛋白2(CAP2)和钙环蛋白结合蛋白(CACYBP)被确定为kNsDEPs。这些kNsDEPs在细胞骨架蛋白结合中起核心作用,对NECC具有强大的诊断能力和特异性。此外,SCGN和CACYBP的同时上调以及CAP2的下调是NECC的一个独特特征,使其与其他神经内分泌癌区分开来。
本研究揭示了kNsDEPs的重要性,并在NECC的背景下阐明了它们的调控网络。它突出了kNsDEPs在NECC诊断中的关键作用,从而为NECC诊断生物标志物的开发提供了有前景的方向。